{"id":"NCT01606176","sponsor":"Jazz Pharmaceuticals","briefTitle":"A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin","officialTitle":"A Multi Centre Randomised, Double Blind, Placebo Controlled, Parallel Group Comparison of the Effects of Cannabis Based Medicine Standardised Extracts Over 4 Weeks, in Patients With Chronic Refractory Pain Due to Multiple Sclerosis or Other Defects of Neurological Function.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-03","primaryCompletion":"2002-08","completion":"2002-08","firstPosted":"2012-05-25","resultsPosted":"2012-08-24","lastUpdate":"2023-01-10"},"enrollment":70,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain","Multiple Sclerosis"],"interventions":[{"type":"DRUG","name":"GW-1000-02","otherNames":["Sativex"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"GW-1000-02","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To investigate the ability of a cannabis based medicine extract to relieve chronic refractory pain of neurological origin.","primaryOutcome":{"measure":"Change From Baseline in Mean Pain Box Scale-11 Score at 3 Weeks.","timeFrame":"0 - 3 weeks","effectByArm":[{"arm":"GW-1000-02","deltaMin":-1.3,"sd":1.67},{"arm":"Placebo","deltaMin":-0.9,"sd":1.62}],"pValues":[{"comp":"OG000 vs OG001","p":"0.332"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":17},"locations":{"siteCount":1,"countries":["United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":36},"commonTop":["Dizziness","Urinary Tract Infection Not Otherwise Specified","Headache Not Otherwise Specified","Nausea","Application Site Pain"]}}